BioMarin Pharmaceutical
BMRN
#1728
Rank
C$17.03 B
Marketcap
C$87.96
Share price
-0.02%
Change (1 day)
19.17%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2026 (TTM): C-$0.13

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is C-$0.13. In 2025 the company made an earnings per share (EPS) of C$2.61 a decrease over its 2024 EPS that were of C$3.22.

EPS history for BioMarin Pharmaceutical from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.13-105.15%
2025C$2.61-19.11%
2024C$3.22152.81%
2023C$1.2715.79%
2022C$1.10-319.62%
2021C-$0.50-107.38%
2020C$6.79-3485.71%
2019C-$0.20-67.44%
2018C-$0.62-34.85%
2017C-$0.95-83.21%
2016C-$5.63263.89%
2015C-$1.5518.68%
2014C-$1.30
2012C-$1.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.84-2,300.59%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
C-$7.43 5,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C-$0.54 322.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02864-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16 22.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$2.59-2,111.11%๐Ÿ‡บ๐Ÿ‡ธ USA